skip to primary navigationskip to content
 

Diabetes UK

Mark

Mark Eccleston

Dr Mark Eccleston has been awarded a three month project grant from Diabetes UK.

Diabetes mellitus is a condition in which the amount of glucose (sugar) in the blood is too high because the body cannot use it properly. There are two main types of diabetes, type I and II. Whilst type II (commonly known as adult onset) can often be controlled in the early stages by diet and exercise and with currently available tablets, later stage type II and all type I diabetics require insulin injections or even insulin pumps in the case of type I diabetes.

The concept of this project is to develop a system that can be taken as a once daily tablet that would allow accurate control of systemic glucose levels without the need for strict regulation of meal times and diet. The tablet would contain glucose responsive nanoparticles that would release insulin when required by the body as glucose levels increased.

This would give a considerable improvement in the quality of life for diabetics in the short term but should also reduce the occurrence of long term health problems associated with diabetes such as heart disease, blindness and peripheral neurodegenerative conditions that are the leading cause of non traumatic amputation.

The funding (£10,000) will provide three months salary and allow Dr Eccleston, as principal investigator, to develop proof of principle for the production of glucose responsive nanoparticles which may eventually lead to the development of an oral, responsive insulin delivery dosage form. If the concept can be developed to this stage then a full project grant can be submitted.

Diabetes UK's Research Fund supports projects that contribute towards an understanding of the causes, prevention or treatment of diabetes and its complications, or the welfare of people with diabetes.

Further information:

RSS Feed Latest news

Alumnus Professor McKinley elected Royal Society Fellow

Apr 23, 2019

Alumnus Professor Gareth McKinley among the 51 distinguished scientists elected as new Royal Society Fellows for his exceptional contribution to science.

Dr Vassiliadis celebrates the contributions of Roger W.H. Sargent at memorial event

Apr 17, 2019

Dr Vassiliadis contributed a talk on optimal control in chemical engineering at a memorial event for Roger W.H. Sargent, founder of process systems engineering.

A chemical garden that’s also a chemical clock

Apr 12, 2019

Research from our Cardoso lab and their colleagues in Spain, published in Angewandte Chemie, combines two classic demos in one beautiful example of active fluid dynamics.

View all news

Upcoming events

CEB Research Conference 2019

Jun 25, 2019

Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS

Machine learning and AI in (bio)chemical engineering

Jul 08, 2019

Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS

Stokes200 Symposium

Sep 15, 2019

Pembroke College, Cambridge

VPF8 Viscoplastic Fluids: from Theory to Application 2019

Sep 16, 2019

Jesus College, Cambridge

Upcoming events